Also known as Lyrica
Pregabalin (INN) (Lyrica) and (Serigaptin) is an anticonvulsant drug used for neuropathic pain and as an adjunct therapy for partial seizures with or without secondary generalization in adults. It has also been found effective for generalized anxiety disorder and is (as of 2007) approved for this use in the European Union. It was designed as a more potent successor to gabapentin. Pregabalin is marketed by Pfizer under the trade name Lyrica. Pfizer described in an SEC filing that the drug could be used to treat epilepsy, post-herpetic neuralgia, diabetic peripheral neuropathy and fibromyalgia. Sales reached a record $3.063 billion in 2010.Source: Wikipedia
Estimated Total Cost: $148.26 for an average of 28 days supply
Patients are most commonly prescribed pregabalin to treat fibromyalgia, degenerative disc disease, peripheral nerve disorder, and complex regional pain syndrome.
Patients taking pregabalin most commonly experience side effects like headache, peripheral edema, and fatigue.
|Disturbance of memory|
|Muscle cramps, contractures, or spasms|
|Shortness of breath|
|Incontinence of stool|
|Alcohol intoxication (Inebriation)|